Optigenex Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Nov 2037
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jul 30, 2027The maintenance fee for Method of enhancing cognition in individuals with at least normal cognition (US 11,883,457) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 16, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 3 of 3
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,098,922 | Increasing telomere length in a cell In force · From the USPTO record | In force | From the USPTO record | |
| US 11,883,457 | Method of enhancing cognition in individuals with at least normal cognition In force · From the USPTO record | In force | From the USPTO record | |
| US 7,579,023 | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals In force Term ended Sep 30, 2026 · From the USPTO record | In force | Term ended Sep 30, 2026 | From the USPTO record |
Also on record, not counted in the 3: 1 lapsed for an unpaid fee · 10 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
Every application published under this name has become a patent.